Roberts, John D.

The accuracy of reverse transcriptase from HIV-1

Roberts, J. D., Bebenek, K., & Kunkel, T. A. (1988) · Science

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 997

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial

Himelstein, A. L., Foster, J. C., Khatcheressian, J. L., Roberts, J. D., Seisler, D. K., Novotny, P. J., Qin, R., Go, R. S., Grubbs, S. S., O’Connor, T., et al. (2017) · JAMA

Bone health and treatmentsBone health and osteoporosis research

Cited by 356

Fidelity of Two Retroviral Reverse Transcriptases during DNA-Dependent DNA Synthesis In Vitro

Roberts, J. D., Preston, B. D., Johnston, L. A., Soni, A., Loeb, L. A., & Kunkel, T. A. (1989) · Molecular and Cellular Biology

Evolution and Genetic DynamicsDNA and Nucleic Acid Chemistry

Cited by 189

Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine

Roberts, J. D., Gennings, C., & Shih, M. (2006) · European Journal of Pharmacology

Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments

Cited by 103

A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma

Holkova, B., Zingone, A., Kmieciak, M., Bose, P., Badros, A. Z., Voorhees, P. M., Baz, R., Korde, N., Lin, H.-Y., Chen, J.-Q., et al. (2016) · Clinical Cancer Research

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research

Cited by 48